Patient Access

Truveris’ Life Sciences data science team conducted a deep-dive analysis to assess the impact of COVID-19 on prescribing and claim volume throughout an 18-month span.

Loss of exclusivity can feel like a dramatic shift, forever changing a drug’s profitability. However, this doesn’t have to be your brand’s fate.

Many Medicare patients end up not filling their high-cost prescriptions due to the Medicare coverage gap. What can manufacturers do to help Medicare patients stay adherent? 

Using simple patient inputs to provide a customized view of specific coverage restrictions and out-of-pocket cost obligations, real-time benefits checks empower patients and providers to make informed decisions about care.

Adopting these three approaches can help manufacturers to build a more effective affordability program. 

You likely already know what patient abandonment is: when a prescription is written by a doctor but never picked up at the pharmacy.